Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormone receptor profile of apocrine lesions of the breast.

Literature DB >> 12846876

Hormone receptor profile of apocrine lesions of the breast.

Michelle Sapp, Abha Malik, Wedad Hanna.

Abstract

Entities: Gene

Mesh：

Substances：
Receptors, Steroid

Year: 2003 PMID： 12846876 DOI： 10.1046/j.1524-4741.2003.09422.x

Source DB: PubMed Journal: Breast J ISSN： 1075-122X Impact factor: 2.431

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Management of unusual histological types of breast cancer.

Authors: Karen A Cadoo; Orla McArdle; Anne-Marie O'Shea; Colm P Power; Bryan T Hennessy
Journal: Oncologist Date: 2012-07-23

Review 2. The enigmatic nature of apocrine breast lesions.

Authors: P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal: Virchows Arch Date: 2006-03-29 Impact factor: 4.064

3. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Authors: Julio E Celis; Teresa Cabezón; José M A Moreira; Pavel Gromov; Irina Gromova; Vera Timmermans-Wielenga; Takuji Iwase; Futoshi Akiyama; Naoko Honma; Fritz Rank
Journal: Mol Oncol Date: 2009-02-03 Impact factor: 6.603

Review 4. Non-operative breast pathology: apocrine lesions.

Authors: C A Wells; G A El-Ayat
Journal: J Clin Pathol Date: 2007-12 Impact factor: 3.411

5. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.

Authors: Pavel Gromov; Jaime A Espinoza; Maj-Lis Talman; Naoko Honma; Niels Kroman; Vera Timmermans Wielenga; José M A Moreira; Irina Gromova
Journal: PLoS One Date: 2014-11-12 Impact factor: 3.240

10. Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.

Authors: Koichi Kubouchi; Kyosuke Shimada; Takamichi Yokoe; Yutaka Tsutsumi
Journal: Technol Cancer Res Treat Date: 2020 Jan-Dec

10 in total

Hormone receptor profile of apocrine lesions of the breast.

Review 1. Management of unusual histological types of breast cancer.

Review 2. The enigmatic nature of apocrine breast lesions.

3. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Review 4. Non-operative breast pathology: apocrine lesions.

5. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.

6. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.

7. Primary cutaneous apocrine gland carcinoma from areolar tissue in a male patient with gynecomastia: a case report.

8. Squamous cell carcinoma with apocrine features of the breast: A case report.

9. Clinicopathological study of a dimorphic variant of breast carcinoma.

10. Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.